I edited a source name out of the above post... we don't discuss sources here.
Thanks I didn't mean to. Didn't even realize I had until I saw the snip!
I edited a source name out of the above post... we don't discuss sources here.
Just talked to Dr. Nichols and he's told me when they ran tests on pargy-lad and it was inactive.
I've asked him for more details on this such as amounts used and other things. I'll post his reply once he messages back.
Also relative to PARGY-LAD being inactive, Dr. Nichols said, "A few milligrams was enough for receptor binding and some rat tests." He's not always the most descriptive and helpful source of information but I think that it speaks volumes...more so than the limited testing shulgin did.
Well, Dr. Nichols is also on record as saying that the NBOMEs are inactive. Which, given that they need to be dosed sublingually to get the optimal effect, is not surprising at all - I don't suppose that the lab rats who partook in the NBOMe tests were taught to hold a blotter under their tongue and make sure not to swallow salivaThat sort of thing is inevitably going to happen if you are not allowed to let a human lab animal have a go at the compound.
Although, if they did not find activity with in vitro receptor binding tests, that does sound pretty damning, I suppose.
Correct me if I am wrong, but wasn't Pargy-LAD only mentioned as a hypothetical possibility in TIHKAL, and never actually bio-assayed by Shulgin (at least that we know of)? I don't have the full TIHKAL book, I'm afraid - I'd love to get an e-book version, but sadly it's not available.
Although, if they did not find activity with in vitro receptor binding tests, that does sound pretty damning, I suppose.
Correct me if I am wrong, but wasn't Pargy-LAD only mentioned as a hypothetical possibility in TIHKAL, and never actually bio-assayed by Shulgin (at least that we know of)?
I have heard a rumor that this was a deliberate attempt to prevent it reaching the market. Almost all early animal trials will be IP or IV because of the inconsistency of other ROAsWell, Dr. Nichols is also on record as saying that the NBOMEs are inactive. Which, given that they need to be dosed sublingually to get the optimal effect, is not surprising at all - I don't suppose that the lab rats who partook in the NBOMe tests were taught to hold a blotter under their tongue and make sure not to swallow salivaThat sort of thing is inevitably going to happen if you are not allowed to let a human lab animal have a go at the compound.
The second half of the book (chemistry and assays) is available through erowid. The first part of the book isn't and is well worth buying a copy for.Correct me if I am wrong, but wasn't Pargy-LAD only mentioned as a hypothetical possibility in TIHKAL, and never actually bio-assayed by Shulgin (at least that we know of)? I don't have the full TIHKAL book, I'm afraid - I'd love to get an e-book version, but sadly it's not available.
Who knows what happens to the molecule in the presence of enzymes. The bioassay is the definitive test.
You're wrong.From TiHKAL (the chemical story is available free at Erowid, among other places): N-Propynyl-nor-LSD (PARGY-LAD). Some activity at 160 µg. Active at 500 µg.
First of all I wouldn't say he's wrong.... Some activity at 160 µg. Active at 500 µg is hardly a description. ... When people read from shulgin, "Some activity at 160 µg. Active at 500 µg.", they typically take it as truth and I argue it needs to be taken with a grain of salt.
Mr Weirdling mentioned that PARGY-LAD may only have been a 'hypothetical possibility' (unsertandably, since he or she hadn't read the PRO-LAD TiHKAL entry), but I would hope we all trust Mr Shulgin enough to believe the compound actually exists. As for whether Sasha tried (or synthesised) it himself, I don't know. He, in turn, may be placing trust in whatever was reported in the literature. There are clearly many things up in the air here, but I'd still trust Shulgin's secondary reporting of activity in a bioassay over reported in vitro receptor binding results (especially given what Transform said) in terms of predicting activity.
If what you're saying is that 500 µg might not be (anywhere near) an average single dose, I agree that that is a possibility.
TIHKAL said:With success in the preparation of the rather stable nor-LSD intermediate, any number of 6-substituted nor-LSD homologues and analogues can be synthesized. Simply use the appropriate alkyl bromide or alkyl iodide and the desired product will be in hand, after a modest amount of rather sophisticated purification at a micro scale. Several analogues are in the chemical literature, and some of them have been explored in direct comparison to LSD. Here are a few examples:
N-Propynyl-nor-LSD (PARGY-LAD). Some activity at 160 µg. Active at 500 µg.
...
Mr Weirdling mentioned that PARGY-LAD may only have been a 'hypothetical possibility' (unsertandably, since he or she hadn't read the PRO-LAD TiHKAL entry), but I would hope we all trust Mr Shulgin enough to believe the compound actually exists. As for whether Sasha tried (or synthesised) it himself, I don't know. He, in turn, may be placing trust in whatever was reported in the literature. There are clearly many things up in the air here, but I'd still trust Shulgin's secondary reporting of activity in a bioassay over reported in vitro receptor binding results (especially given what Transform said) in terms of predicting activity.
If what you're saying is that 500 µg might not be (anywhere near) an average single dose, I agree that that is a possibility.
I located the 1985 "Synthesis and LSD-like discriminative stimulus properties in a series of N(6)-alkyl norlysergic acid N,N-diethylamide derivatives" article from David Nichols which is mentioned on the PARGY-LAD wikipedia page. Well, wherever did the reference for the 160ug and 500ug numbers come from, it wasn't from this paper. To be perfectly honest, I don't even know if this paper discusses PARGY-LAD at all. I gave decoding the formulas an honest try, but I failed.
I agree I still supporr his secondary testing but almost know comments on effects of that's subs screams to me he used literature not testing. Heck even in pihkal chapeter 3 he mentions is how he orders lsd as as apposed to making it. Look into chapter 3
I do not believe the paper discussed PARGY LAD at all.
To clarify, Nichols supposedly only misled about the NBOMes because he didn't want the "cat to leave the bag" so to speak. This wouldn't be an issue with PARGY-LAD and I would take his comments on it at face value.
As a matter of fact, I have found AL-LAD more delightful than LSD in all departments. Whereas LSZ was nothing like it, absolutely different character to this one. Lysergamides are pretty unique and hold a great potential imho.
Please note that the supplier of this (fake) "PARGY-LAD" now also sold illegal Cathinone as "4-AcO-DALT", see WEDINOS sample W002700.
Don't trust the product, don't trust the vendor.